 |
Previous Article | Next Article 
Journal of Neuroscience, Vol 12, 3071-3083, Copyright © 1992 by Society for Neuroscience
Phosphorylation of DARPP-32 and protein phosphatase inhibitor-1 in rat choroid plexus: regulation by factors other than dopamine
GL Snyder, JA Girault, JY Chen, AJ Czernik, JW Kebabian, JA Nathanson and P Greengard
Laboratory of Molecular and Cellular Neuroscience, Rockefeller University, New York, New York 10021.
The molecular mechanisms underlying regulation of fluid production by
secretory epithelia such as the choroid plexus are poorly understood. Two
cAMP-regulated inhibitors of protein phosphatase-1, inhibitor-1 (I1) and a
dopamine- and cAMP-regulated phosphoprotein, M(r) = 32,000 (DARPP-32), are
enriched in the choroid plexus. We show here that these two phosphoproteins
are colocalized in choroid plexus epithelial cells. We have developed a
novel method for studying the phosphorylation state of DARPP-32 and I1 in
intact cells, using a phosphorylation state- specific monoclonal antibody.
Several drugs and hormones that are known to alter fluid secretion and that
increase cAMP levels (forskolin, isoproterenol, vasoactive intestinal
peptide) or cGMP levels (atrial natriuretic peptide) or that may use
additional second messenger pathways (5-HT), increase the phosphorylation
of I1 and DARPP-32 in rat choroid plexus. In contrast, dopamine does not
alter cAMP and cGMP levels, or I1 and DARPP-32 phosphorylation. Our results
indicate that DARPP-32, known to be regulated by dopamine in a number of
tissues, can be phosphorylated in response to non-dopaminergic factors,
including hormones acting through non-cAMP-dependent pathways. Our results
also raise the possibility that inhibition of phosphatase-1, as a result of
I1 and DARPP-32 phosphorylation, might be part of a final common pathway in
the action of several factors that are known or thought to alter
cerebrospinal fluid production.
This article has been cited by other articles:

|
 |

|
 |
 
S. Kitaoka, T. Furuyashiki, A. Nishi, T. Shuto, S. Koyasu, T. Matsuoka, M. Miyasaka, P. Greengard, and S. Narumiya
Prostaglandin E2 Acts on EP1 Receptor and Amplifies Both Dopamine D1 and D2 Receptor Signaling in the Striatum
J. Neurosci.,
November 21, 2007;
27(47):
12900 - 12907.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Santini, E. Valjent, A. Usiello, M. Carta, A. Borgkvist, J.-A. Girault, D. Herve, P. Greengard, and G. Fisone
Critical Involvement of cAMP/DARPP-32 and Extracellular Signal-Regulated Protein Kinase Signaling in L-DOPA-Induced Dyskinesia
J. Neurosci.,
June 27, 2007;
27(26):
6995 - 7005.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Nguyen, A. Nishi, J. W. Kansy, J. Fernandez, K. Hayashi, F. Gillardon, H. C. Hemmings Jr., A. C. Nairn, and J. A. Bibb
Regulation of Protein Phosphatase Inhibitor-1 by Cyclin-dependent Kinase 5
J. Biol. Chem.,
June 1, 2007;
282(22):
16511 - 16520.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Svenningsson, E. T. Tzavara, H. Qi, R. Carruthers, J. M. Witkin, G. G. Nomikos, and P. Greengard
Biochemical and Behavioral Evidence for Antidepressant-Like Effects of 5-HT6 Receptor Stimulation
J. Neurosci.,
April 11, 2007;
27(15):
4201 - 4209.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Sahin, H. Shu, J. Fernandez, A. El-Armouche, J. D. Molkentin, A. C. Nairn, and J. A. Bibb
Phosphorylation of Protein Phosphatase Inhibitor-1 by Protein Kinase C
J. Biol. Chem.,
August 25, 2006;
281(34):
24322 - 24335.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Zhang, P. Svenningsson, R. Picetti, S. D. Schlussman, A. C. Nairn, A. Ho, P. Greengard, and M. J. Kreek
Cocaine self-administration in mice is inversely related to phosphorylation at Thr34 (protein kinase A site) and Ser130 (kinase CK1 site) of DARPP-32.
J. Neurosci.,
March 8, 2006;
26(10):
2645 - 2651.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Hamada, J. P. Hendrick, G. R. Ryan, M. Kuroiwa, H. Higashi, M. Tanaka, A. C. Nairn, P. Greengard, and A. Nishi
Nicotine Regulates DARPP-32 (Dopamine- and cAMP-Regulated Phosphoprotein of 32 kDa) Phosphorylation at Multiple Sites in Neostriatal Neurons
J. Pharmacol. Exp. Ther.,
November 1, 2005;
315(2):
872 - 878.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Zhao, S. Zhuang, Y. Chen, G. R. Boss, and R. B. Pilz
Cyclic GMP-dependent Protein Kinase Regulates CCAAT Enhancer-binding Protein {beta} Functions through Inhibition of Glycogen Synthase Kinase-3
J. Biol. Chem.,
September 23, 2005;
280(38):
32683 - 32692.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Andersson, A. Usiello, A. Borgkvist, L. Pozzi, C. Dominguez, A. A. Fienberg, P. Svenningsson, B. B. Fredholm, E. Borrelli, P. Greengard, et al.
Cannabinoid Action Depends on Phosphorylation of Dopamine- and cAMP-Regulated Phosphoprotein of 32 kDa at the Protein Kinase A Site in Striatal Projection Neurons
J. Neurosci.,
September 14, 2005;
25(37):
8432 - 8438.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Maton, T. Lorca, J.-A. Girault, R. Ozon, and C. Jessus
Differential regulation of Cdc2 and Aurora-A in Xenopus oocytes: a crucial role of phosphatase 2A
J. Cell Sci.,
June 1, 2005;
118(11):
2485 - 2494.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Takahashi, T. Ohshima, A. Cho, T. Sreenath, M. J. Iadarola, H. C. Pant, Y. Kim, A. C. Nairn, R. O. Brady, P. Greengard, et al.
Increased activity of cyclin-dependent kinase 5 leads to attenuation of cocaine-mediated dopamine signaling
PNAS,
February 1, 2005;
102(5):
1737 - 1742.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Nishi, Y. Watanabe, H. Higashi, M. Tanaka, A. C. Nairn, and P. Greengard
Glutamate regulation of DARPP-32 phosphorylation in neostriatal neurons involves activation of multiple signaling cascades
PNAS,
January 25, 2005;
102(4):
1199 - 1204.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. El-Armouche, T. Pamminger, D. Ditz, O. Zolk, and T. Eschenhagen
Decreased protein and phosphorylation level of the protein phosphatase inhibitor-1 in failing human hearts
Cardiovasc Res,
January 1, 2004;
61(1):
87 - 93.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Lindgren, A. Usiello, M. Goiny, J. Haycock, E. Erbs, P. Greengard, T. Hokfelt, E. Borrelli, and G. Fisone
Distinct roles of dopamine D2L and D2S receptor isoforms in the regulation of protein phosphorylation at presynaptic and postsynaptic sites
PNAS,
April 1, 2003;
100(7):
4305 - 4309.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. M. Reed, D. R. Repaske, G. L. Snyder, P. Greengard, and C. V. Vorhees
Phosphodiesterase 1B Knock-Out Mice Exhibit Exaggerated Locomotor Hyperactivity and DARPP-32 Phosphorylation in Response to Dopamine Agonists and Display Impaired Spatial Learning
J. Neurosci.,
June 15, 2002;
22(12):
5188 - 5197.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Svenningsson, E. T. Tzavara, J. M. Witkin, A. A. Fienberg, G. G. Nomikos, and P. Greengard
Involvement of striatal and extrastriatal DARPP-32 in biochemical and behavioral effects of fluoxetine (Prozac)
PNAS,
March 5, 2002;
99(5):
3182 - 3187.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Z. Ellis, J. A. Nathanson, J. Rabe, and K. J. Sweadner
Carbachol and Nitric Oxide Inhibition of Na,K-ATPase Activity in Bovine Ciliary Processes
Invest. Ophthalmol. Vis. Sci.,
October 1, 2001;
42(11):
2625 - 2631.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Z. Ellis, J. A. Nathanson, and K. J. Sweadner
Carbachol inhibits Na+-K+-ATPase activity in choroid plexus via stimulation of the NO/cGMP pathway
Am J Physiol Cell Physiol,
December 1, 2000;
279(6):
C1685 - C1693.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Calabresi, P. Gubellini, D. Centonze, B. Picconi, G. Bernardi, K. Chergui, P. Svenningsson, A. A. Fienberg, and P. Greengard
Dopamine and cAMP-Regulated Phosphoprotein 32 kDa Controls Both Striatal Long-Term Depression and Long-Term Potentiation, Opposing Forms of Synaptic Plasticity
J. Neurosci.,
November 15, 2000;
20(22):
8443 - 8451.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. P. Brown, R. D. Blitzer, J. H. Connor, T. Wong, S. Shenolikar, R. Iyengar, and E. M. Landau
Long-Term Potentiation Induced by theta Frequency Stimulation Is Regulated by a Protein Phosphatase-1-Operated Gate
J. Neurosci.,
November 1, 2000;
20(21):
7880 - 7887.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Nishi, J. A. Bibb, G. L. Snyder, H. Higashi, A. C. Nairn, and P. Greengard
Amplification of dopaminergic signaling by a positive feedback loop
PNAS,
October 23, 2000;
(2000)
220410397.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
G. L. Snyder, P. B. Allen, A. A. Fienberg, C. G. Valle, R. L. Huganir, A. C. Nairn, and P. Greengard
Regulation of Phosphorylation of the GluR1 AMPA Receptor in the Neostriatum by Dopamine and Psychostimulants In Vivo
J. Neurosci.,
June 15, 2000;
20(12):
4480 - 4488.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Svenningsson, M. Lindskog, C. Ledent, M. Parmentier, P. Greengard, B. B. Fredholm, and G. Fisone
Regulation of the phosphorylation of the dopamine- and cAMP-regulated phosphoprotein of 32 kDa in vivo by dopamine D1, dopamine D2, and adenosine A2A receptors
PNAS,
February 15, 2000;
97(4):
1856 - 1860.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. GUDI, G. K.-P. HONG, A. B. VAANDRAGER, S. M. LOHMANN, and R. B. PILZ
Nitric oxide and cGMP regulate gene expression in neuronal and glial cells by activating type II cGMP-dependent protein kinase
FASEB J,
December 1, 1999;
13(15):
2143 - 2152.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. Mayerhofer, H. C. Hemmings Jr., G. L. Snyder, P. Greengard, S. Boddien, U. Berg, and C. Brucker
Functional Dopamine-1 Receptors and DARPP-32 Are Expressed in Human Ovary and Granulosa Luteal Cells in Vitro
J. Clin. Endocrinol. Metab.,
January 1, 1999;
84(1):
257 - 264.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. M. Meredith, C. A. Moffatt, A. P. Auger, G. L. Snyder, P. Greengard, and J. D. Blaustein
Mating-Related Stimulation Induces Phosphorylation of Dopamine- and Cyclic AMP-Regulated Phosphoprotein-32 in Progestin Receptor-Containing Areas in the Female Rat Brain
J. Neurosci.,
December 1, 1998;
18(23):
10189 - 10195.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. H. Connor, H. N. Quan, N. T. Ramaswamy, L. Zhang, S. Barik, J. Zheng, J. F. Cannon, E. Y. C. Lee, and S. Shenolikar
Inhibitor-1 Interaction Domain That Mediates the Inhibition of Protein Phosphatase-1
J. Biol. Chem.,
October 16, 1998;
273(42):
27716 - 27724.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. D. Blitzer, J. H. Connor, G. P. Brown, T. Wong, S. Shenolikar, R. Iyengar, and E. M. Landau
Gating of CaMKII by cAMP-Regulated Protein Phosphatase Activity During LTP
Science,
June 19, 1998;
280(5371):
1940 - 1943.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
D. W. Self, L. M. Genova, B. T. Hope, W. J. Barnhart, J. J. Spencer, and E. J. Nestler
Involvement of cAMP-Dependent Protein Kinase in the Nucleus Accumbens in Cocaine Self-Administration and Relapse of Cocaine-Seeking Behavior
J. Neurosci.,
March 1, 1998;
18(5):
1848 - 1859.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. R. Bennett
Monoaminergic synapses and schizophrenia: 45 years of neuroleptics
J Psychopharmacol,
January 1, 1998;
12(3):
289 - 304.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Nishi, G. L. Snyder, and P. Greengard
Bidirectional Regulation of DARPP-32 Phosphorylation by Dopamine
J. Neurosci.,
November 1, 1997;
17(21):
8147 - 8155.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Marin, K. L. Nastiuk, N. Daniel, J.-A. Girault, A. J. Czernik, J. Glowinski, A. C. Nairn, and J. Premont
Glutamate-Dependent Phosphorylation of Elongation Factor-2 and Inhibition of Protein Synthesis in Neurons
J. Neurosci.,
May 15, 1997;
17(10):
3445 - 3454.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-G. Kwon, S. Y. Lee, Y. Choi, P. Greengard, and A. C. Nairn
Cell cycle-dependent phosphorylation of mammalian protein phosphatase 1 by cdc2 kinase
PNAS,
March 18, 1997;
94(6):
2168 - 2173.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Bibb, Z. Yan, P. Svenningsson, G. L. Snyder, V. A. Pieribone, A. Horiuchi, A. C. Nairn, A. Messer, and P. Greengard
Severe deficiencies in dopamine signaling in presymptomatic Huntington's disease mice
PNAS,
June 6, 2000;
97(12):
6809 - 6814.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Nishi, J. A. Bibb, G. L. Snyder, H. Higashi, A. C. Nairn, and P. Greengard
Amplification of dopaminergic signaling by a positive feedback loop
PNAS,
November 7, 2000;
97(23):
12840 - 12845.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|